Sherbrooke Park Advisers LLC Neogenomics Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 11,102 shares of NEO stock, worth $106,801. This represents 0.06% of its overall portfolio holdings.
Number of Shares
11,102Holding current value
$106,801% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$137 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$62.8 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$59.3 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$59.2 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.21B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...